Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a ...

Conservation scientists are racing against time, as hundreds of animal and plant species edge closer to extinction each year ...

Bill Gates's comments on genetics as "code" have reignited debate over genetic engineering, intellectual property, and the ...

Explore the "Top 10 Smart Ideas" that are reshaping the way we think and live. This captivating video highlights innovative ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Vaso-occlusion: Sickled cells block small blood vessels, impeding blood flow and oxygen delivery to tissues and organs. This ...

We’re talking about biotechnology and agriculture working together to figure out how we’ll feed everyone in the years to come ...

At the University of Illinois, we’ve discovered that faith and science, united through dialogue and understanding, is our ...

Easton R. White is an assistant professor of biology at the University of New Hampshire who studies biodiversity and ...

Australian researchers found that a neuropeptide fueled tumor growth in vitro, but deletion of its receptor halted the ...

A newly discovered nuclear role for HSL reveals how imbalances in its location within fat cells may contribute to both ...

Onion crops face disease challenges. New gene editing tech boosts resistance by precisely modifying plant genes, unlike slow ...